Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of Biological Chemistry|June 5, 2004
Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activityNatasa Zamurovic, David Cappellen, Daisy Rohner, et al.Bone|March 23, 2005
Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodentsMichaela Kneissel, Anne Studer, Reto Cortesi, et al.Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Studying gene expression in bone by in situ hybridizationIna Kramer, Rishard Salie, Mira Susa, et al.Journal of Translational Medicine|March 18, 2004
Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assayMira Susa, Ngoc-Hong Luong-Nguyen, David Cappellen, et al.Calcified Tissue International|September 3, 2008
A rapid, nonradioactive in situ hybridization technique for use on cryosectioned adult mouse boneRishard Salie, Haitao Li, Xi Jiang, et al.The Journal of Biological Chemistry|March 30, 2002
Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa BDavid Cappellen, Ngoc-Hong Luong-Nguyen, Sandrine Bongiovanni, et al.Journal of Cellular Physiology|May 27, 2003
EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytesTormod K Guren, John Ødegård, Hilde Abrahamsen, et al.Bone|October 28, 2009
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in boneRishard Salie, Michaela Kneissel, Mirko Vukevic, et al.Bone|January 31, 2004
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathwayIrene Recchia, Nadia Rucci, Alessia Funari, et al.The Journal of Pharmacology and Experimental Therapeutics|April 22, 2006
Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapyNadia Rucci, Irene Recchia, Adriano Angelucci, et al.Pageof 2